Researchers testing the effect of immune drug "ipilimumab" on prostate cancer were startled recently by the results. (BBC) In three men with advanced (usually terminal) prostate cancer, the tumors shrank to the point where surgeons could operate.
"Our surgeons had never seen this happen before," said one researcher. "The pathologist (who was working during surgery) asked if we were sending him samples from the same patient."
Further testing is required to see whether or not the results can be reproduced or if they were just a, you know, miracle.
Subscribe to:
Post Comments (Atom)
About Me
- pound360
- I started pound360 to channel my obsession with vitamins, running and the five senses. Eventually, I got bored focusing on all that stuff, so I came back from a one month hiatus in May of 2007 (one year after launching Pound360) and broadened my mumblings here to include all science.
Posts
No comments:
Post a Comment